Significant overlap has been identified in the pathophysiological mechanisms of metabolic diseases, such as T2D, neurodegenerative disorders, and AD, and in particular the alteration of insulin signaling is a shared hallmark of these conditions, still not fully understood from a molecular point of view. This evidence concerns the gene INS and Other metabolic disease.